ICE Regimen for Relapsed/Refractory Bone and Soft Tissue Sarcomas in Children

---

Atıf İçin Kopyala

AYDIN G. B., AKYÜZ C., VARAN A., YALÇIN B., KURUCU N., Kutluk T.

REVIEWS ON RECENT CLINICAL TRIALS, cilt.13, sa.2, ss.126-131, 2018 (ESCI)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 13 Sayı: 2
• Basım Tarihi: 2018
• Doi Numarası: 10.2174/1574887113666180124114818
• Dergi Adı: REVIEWS ON RECENT CLINICAL TRIALS
• Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
• Sayfa Sayıları: ss.126-131
• Hacettepe Üniversitesi Adresli: Evet

Özet

Background: The outcome of bone and soft tissue sarcomas (BST) after relapse has very poor prognosis with survival rates less than 39%. Unfortunately there are not many treatment options, but promising responses have been reported with ifosfamide, etoposide and carboplatin (ICE).